(Q53858341)

21 May 2018

title

Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. (English)

1 reference

21 May 2018

main subject

arterial hypertension

0 references

United States of America

0 references

1 reference

2

1 reference

21 May 2018

author name string

Blythe WB

series ordinal

1

1 reference

21 May 2018

publication date

1 July 1991

1 reference

21 May 2018

number of pages

5

1 reference

American Journal of Kidney Diseases

inferred from page(s)

published in

1 reference

21 May 2018

volume

18

1 reference

21 May 2018

issue

1

1 reference

21 May 2018

page(s)

33-37

1 reference

21 May 2018

Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. Hypertension Detection and Follow-up Program Cooperative Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Prognostic factors in the treatment of mild hypertension. The Management Committee of the Australian National Blood Pressure Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

High blood pressure is a major factor in progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Racial differences in the incidence of treatment for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Renal insufficiency in treated essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Systemic hypertension and the kidney in black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

The incidence of treated end stage renal disease in the eastern United States: 1973-1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Renal Vasculature in Essential Hypertension: Racial Differences

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

Target organ damage in black hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980287-3

7 January 2021

10.1016/S0272-6386(12)80287-3

Identifiers

DOI

1 reference

21 May 2018

release_go6zatdigjdbbkg4rgbu3qjbnq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/go6zatdigjdbbkg4rgbu3qjbnq

24 November 2022

mapped directly with Wikidata item

1 reference

21 May 2018